Details for Patent: 10,765,820

Which drugs does patent 10,765,820 protect, and when does it expire?

Patent 10,765,820 protects PROAIR DIGIHALER, PROAIR RESPICLICK, AIRDUO DIGIHALER, AIRDUO RESPICLICK, ARMONAIR DIGIHALER, and ARMONAIR RESPICLICK, and is included in three NDAs.

Protection for AIRDUO DIGIHALER has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifteen patent family members in fourteen countries.

Summary for Patent: 10,765,820

Title:	Dry powder inhalation apparatus
Abstract:	A dry powder inhalation apparatus includes a housing, a reservoir for medicament located within the housing, a mouthpiece disposed on the housing for insertion in the mouth of a user for inhalation of a predetermined dose of medicament, a delivery channel between a discharge outlet of the reservoir and the mouthpiece for delivering the predetermined dose of medicament, a device positioned within the housing and normally held adjacent the reservoir for receiving the predetermined dose of medicament from the discharge outlet and transferring it to the delivery channel, and a release mechanism adapted to release the device and permit controlled movement thereof to the delivery channel for the delivery, the release mechanism being located at least partially outside of the housing for manual operation by the user.
Inventor(s):	Barney; Brian (Essex, GB), O'Leary; David (Essex, GB), Striebig; Rachel (London, GB)
Assignee:	NORTON HEALTHCARE LTD. (London, GB)
Application Number:	15/235,794
Patent Claim Types: see list of patent claims	Delivery; Device;

Drugs Protected by US Patent 10,765,820

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Teva Branded Pharm	PROAIR DIGIHALER	albuterol sulfate	POWDER, METERED;INHALATION	205636-002	Dec 21, 2018		RX	Yes	No			Y
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015		RX	Yes	Yes			Y
Teva Pharm	AIRDUO DIGIHALER	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	208799-004	Jul 12, 2019		RX	Yes	No					Y

Foreign Priority and PCT Information for Patent: 10,765,820

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0323085.1	Oct 2, 2003

International Family Members for US Patent 10,765,820

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	506094
Australia	2004279379
Canada	2540580